Dupilumab; upadacitinib (Review of cost-effectiveness of drugs for atopic dermatitis) – November 2023

Review of the Cost-Effectiveness of Drugs for Atopic Dermatitis: Dupilumab: Injection 200 mg in 1.14 mL single dose pre-filled syringe, Injection 300 mg in 2 mL single dose pre-filled syringe; Dupixent®; and Upadacitinib: Tablet 15 mg, Tablet 30 mg; Rinvoq®